Targeting Enhancer Switching Overcomes Non-Genetic Drug Resistance in Acute Myeloid Leukaemia

Nature Communications - United Kingdom
doi 10.1038/s41467-019-10652-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Acute Aleukaemic Myeloid Leukaemia

BMJ
1943English

Prognosis in Acute Myeloid Leukaemia.

BMJ
1981English

Zoledronic Acid Overcomes Adriamycin Resistance in Acute Myeloid Leukemia Cells by Promoting Apoptosis

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2016English

Targeting Oncoprotein Stability Overcomes Drug Resistance Caused by FLT3 Kinase Domain Mutations

PLoS ONE
Multidisciplinary
2014English

Razoxane in Treatment of Acute Myeloid Leukaemia.

BMJ
1978English

Cord Blood Transplant for Acute Myeloid Leukaemia

British Journal of Haematology
Hematology
2016English

Isolated CNS Leukaemic Relapse in Acute Myeloid Leukaemia

BMJ Case Reports
Medicine
2019English

Targeting C-Met Receptor Overcomes TRAIL-Resistance in Brain Tumors

PLoS ONE
Multidisciplinary
2014English

High Expression of Myocyte Enhancer Factor 2C Predicts Poor Prognosis for Adult Acute Myeloid Leukaemia With Normal Karyotype

British Journal of Haematology
Hematology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy